3-hydrazino-1,2-benzisothiazole 1,1-dioxide derivatives
CA 1250848 A · Owner: Bayer Aktiengesellschaft · Inventors: Hanssler, Gerd; Hajek, Manfred; Salzburg, Herbert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract, Compounds of the formula in which, R1 is alkyl, cycloalkyl, aryl or hydrogen R2 is -Co-R3, R3 is alkyl, alkenyl or cycloalkyl or is, phenyl which is optionally substituted or is alkoxy or benzyl, or is phenoxy which is optionally substituted, or is phenoxymethyl, alkylamino, cycloalkylamino or phenylamlno, or, R1 and R2 together are a group, R4 and R5 each independently is hydrogen alkyl, cycloalkenyl or phenylalkenyl, or is phenyl which is optionally substituted by alkyl, halogen and/or alkoxy, or is furyl, or, R4 and R5 together are alkylene having 4 to 6 carbon atoms, are fungicidally active. Those compounds wherein R3 is alkylamino, cycloalkylamino or phenylamino with the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 7, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 7, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.